Home » FDC Obtains FDA Approval for Ciprofloxacin Opthalmic Solution
FDC Obtains FDA Approval for Ciprofloxacin Opthalmic Solution
FDC announced that the company has obtained an approval from US FDA for its Abbreviated New Drug Application Ciprofloxacin Ophthalmic Solution that is used for occular surface infections.
RTTNews
RTTNews
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May